Shanghai Pulmonary Hospital
Tracked across 1 events · 6 articles · First seen Sep 10, 2026 · Last active Sep 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Insilico Medicine announced on September 9-10, 2026 that it has dosed the first patient with Rentosertib (ISM001-055 / INS018_055) in GENESIS-IPF-3, a Phase III clinical trial for idiopathic pulmonary fibrosis (IPF), at United Medical College…
Impact: Shanghai Pulmonary Hospital enrolled its first patient on the same day and its President, Chang Chen, serves as a Co-Leading Principal Investigator. This highlights the hospital's participation in the pivotal trial.
Sep 10, 2026 · 6 articles
40
Shanghai Pulmonary Hospital enrolled first patientInsilico Rentosertib Phase...
ERGEN INTELLIGENCE
Track Shanghai Pulmonary Hospital live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard